Peng Wang

Peng Wang, Ph.D., is an Associate Director of R&D Analytical Innovation at Lonza, with a background that includes roles as Senior Scientist and Scientist II in CDMO services and collaborative innovation. Peng is an active member of the ATMP working group at The British Pharmacopoeia and previously served as a Senior Research Scientist at MD Anderson Cancer Center. Prior academic experience includes a postdoctoral fellowship at Harvard University. Peng Wang earned a Doctor of Philosophy (PhD) in Chemical and Biomolecular Engineering from UCLA between 2009 and 2013.